Matches in SemOpenAlex for { <https://semopenalex.org/work/W4320179229> ?p ?o ?g. }
- W4320179229 abstract "Abstract Pancreatic carcinoma is one of the most lethal cancers and the absence of efficient therapeutic strategies results in poor prognosis. Transcriptional dysregulation due to alterations in KRAS and MYC impacts initiation, development, and survival of this tumor type. Using patient-derived xenografts of pancreatic carcinoma driven by KRAS and MYC oncogenic transcription, we show that co-inhibition of Topoisomerase 1 (TOP1) and bromodomain containing protein 4 (BRD4) synergistically induce tumor regression through targeting promoter pause-release, a rate-limiting step in transcription elongation. By comparing the nascent transcriptome with the recruitment of elongation and termination factors along genes, we found that co-inhibition of TOP1 and BRD4, while globally impairing RNA production, disturbs recruitment of proteins involved in termination. Thus, RNA polymerases continue transcribing downstream of genes for hundreds of kilobases leading to readthrough transcription. This pervasive transcription also occurs during replication, perturbing replisome progression and leading to DNA damage. The synergistic effect of TOP1 and BRD4 inhibition is specific for cancer cells leaving normal cells unharmed, highlighting the sensitivity of the tumor to these transcriptional defects. This preclinical study provides a mechanistic understanding of the benefit of combining TOP1 and BRD4 inhibitors to treat pancreatic carcinomas addicted to oncogenic drivers of high transcription and replication. One Sentence Summary TOP1 and BRD4 inhibitors synergize to selectively kill pancreatic cancer in vivo via readthrough transcription without emergence of drug resistance" @default.
- W4320179229 created "2023-02-13" @default.
- W4320179229 creator A5000239454 @default.
- W4320179229 creator A5000535335 @default.
- W4320179229 creator A5000633602 @default.
- W4320179229 creator A5009500545 @default.
- W4320179229 creator A5012194841 @default.
- W4320179229 creator A5022725766 @default.
- W4320179229 creator A5022846302 @default.
- W4320179229 creator A5023950338 @default.
- W4320179229 creator A5039090640 @default.
- W4320179229 creator A5041673210 @default.
- W4320179229 creator A5053471997 @default.
- W4320179229 creator A5056461677 @default.
- W4320179229 creator A5057812298 @default.
- W4320179229 creator A5058423488 @default.
- W4320179229 creator A5061187515 @default.
- W4320179229 creator A5063601764 @default.
- W4320179229 creator A5067676567 @default.
- W4320179229 creator A5071394674 @default.
- W4320179229 creator A5071888326 @default.
- W4320179229 creator A5083319320 @default.
- W4320179229 creator A5084605370 @default.
- W4320179229 creator A5085907938 @default.
- W4320179229 creator A5090591024 @default.
- W4320179229 creator A5090771124 @default.
- W4320179229 date "2023-02-12" @default.
- W4320179229 modified "2023-10-14" @default.
- W4320179229 title "Co-inhibition of topoisomerase 1 and BRD4-mediated pause release selectively kills pancreatic cancer<i>via</i>readthrough transcription" @default.
- W4320179229 cites W1519422934 @default.
- W4320179229 cites W1548779692 @default.
- W4320179229 cites W1597602621 @default.
- W4320179229 cites W1882171616 @default.
- W4320179229 cites W1964259728 @default.
- W4320179229 cites W1970179483 @default.
- W4320179229 cites W1971075697 @default.
- W4320179229 cites W1971578941 @default.
- W4320179229 cites W1973094248 @default.
- W4320179229 cites W1973462980 @default.
- W4320179229 cites W1979452570 @default.
- W4320179229 cites W1985775217 @default.
- W4320179229 cites W1990320777 @default.
- W4320179229 cites W1996813139 @default.
- W4320179229 cites W2013202994 @default.
- W4320179229 cites W2016326408 @default.
- W4320179229 cites W2022386942 @default.
- W4320179229 cites W2024800350 @default.
- W4320179229 cites W2032742580 @default.
- W4320179229 cites W2040410152 @default.
- W4320179229 cites W2040909468 @default.
- W4320179229 cites W2041156660 @default.
- W4320179229 cites W2045273474 @default.
- W4320179229 cites W2055150965 @default.
- W4320179229 cites W2058940094 @default.
- W4320179229 cites W2060484997 @default.
- W4320179229 cites W2060737851 @default.
- W4320179229 cites W2062702286 @default.
- W4320179229 cites W2064537118 @default.
- W4320179229 cites W2065884484 @default.
- W4320179229 cites W2068577449 @default.
- W4320179229 cites W2074304165 @default.
- W4320179229 cites W2075756021 @default.
- W4320179229 cites W2081567150 @default.
- W4320179229 cites W2085033505 @default.
- W4320179229 cites W2085515847 @default.
- W4320179229 cites W2093777918 @default.
- W4320179229 cites W2096228011 @default.
- W4320179229 cites W2102619694 @default.
- W4320179229 cites W2103441770 @default.
- W4320179229 cites W2106836163 @default.
- W4320179229 cites W2117981755 @default.
- W4320179229 cites W2119186872 @default.
- W4320179229 cites W2121371748 @default.
- W4320179229 cites W2128339707 @default.
- W4320179229 cites W2130109827 @default.
- W4320179229 cites W2130410032 @default.
- W4320179229 cites W2138207763 @default.
- W4320179229 cites W2146274229 @default.
- W4320179229 cites W2147138024 @default.
- W4320179229 cites W2149993601 @default.
- W4320179229 cites W2151253787 @default.
- W4320179229 cites W2152930453 @default.
- W4320179229 cites W2153087859 @default.
- W4320179229 cites W2154191201 @default.
- W4320179229 cites W2154790710 @default.
- W4320179229 cites W2158699530 @default.
- W4320179229 cites W2160463900 @default.
- W4320179229 cites W2165710552 @default.
- W4320179229 cites W2169749676 @default.
- W4320179229 cites W2170551349 @default.
- W4320179229 cites W2171808845 @default.
- W4320179229 cites W2173001211 @default.
- W4320179229 cites W2317936438 @default.
- W4320179229 cites W2326269909 @default.
- W4320179229 cites W2341539131 @default.
- W4320179229 cites W2432815617 @default.
- W4320179229 cites W2465336312 @default.
- W4320179229 cites W2523410070 @default.
- W4320179229 cites W2586373162 @default.
- W4320179229 cites W2589386142 @default.